Momentum Biotechnologies
Momentum Biotechnologies is a drug discovery partner providing specialized mass spectrometry technologies to clients worldwide. Through a diverse array of services, including affinity-selection mass spectrometry (ASMS), covalent binding assays, proteomics / chemoproteomics, small-molecule analysis, and data products, Momentum helps clients identify, validate, and characterize therapeutic leads, accelerating critical drug discovery efforts.
CHIPP™
Chaotrope-induced protein precipitation & proteome profiling (CHIPP™) is a readily scalable, label-free assay for the study of drug: target interactions.
Momentum Biotechnologies is a drug discovery partner providing specialized mass spectrometry technologies to clients worldwide. Through a diverse array of services, including affinity-selection mass spectrometry (ASMS), covalent binding assays, proteomics / chemoproteomics, small-molecule analysis, and data products, Momentum helps clients identify, validate, and characterize therapeutic leads, accelerating critical drug discovery efforts.
Contact Momentum Biotechnologies
3 Federal Street, Suite 300 | Billerica, MA 01821 USA - Lise-Meitner-Strasse 30 | 85354 Freising, Germany
Website link





